Lakeland Regional Medical Center

(863) 687-1100

Lakeland Regional Cancer Center
Lakeland Regional Cancer Center
Lakeland Regional Cancer Center

Print Page

Renal Cell (Kidney) Cancer

Clinical Trial #S0931:

  • Everolimus versus placebo as a way to reduce risk of recurrence for patients who have had a kidney cancer surgically removed.
  • Participants may have either a clear cell or non clear cell renal cancer.  Bilateral tumors are allowed if they were resected.  The participation in this study must start within 84 days of surgery.
  • Exclusions include, but are not limited to:  Prior anti cancer therapy, live vaccine within 7 days, uncontrolled pulmonary disease, severe cardiac disease, cirrhosis or severe liver impairment, HIV and malabsorption syndrome.

© 2014 Lakeland Regional Medical Center